Last fall, a patient named Greg in Austin, Texas, emailed his prescriber three weeks into a sermorelin protocol with a question that comes up constantly: "My buddy does five days on and two off. I'm injecting every night. Am I doing this wrong?" His IGF-1 had already climbed from 118 ng/mL to 187 ng/mL. His sleep had improved noticeably. His prescriber's reply was two sentences: "You're not doing it wrong. He's not doing it wrong either."
That exchange captures the honest state of sermorelin cycling. The three main approaches (5-days-on with 2-days-off, continuous nightly, and 6-months-on with a 1-month break) all have real clinical advocates, and none has clearly superior outcome data over the others. The choice comes down to prescriber philosophy, patient preference, cost, and how the individual responds. Sermorelin is a growth hormone releasing hormone analog, and compounded sermorelin is prescribed off-label by licensed pharmacies for adults under physician supervision.
Here's what actually matters when picking a sermorelin cycle, and what doesn't.
The Receptor Desensitization Question
Cycling exists in peptide protocols because of one core worry: that continuous stimulation of GHRH receptors on the pituitary could dull their responsiveness over time, gradually blunting GH output per dose. Periodic breaks, the thinking goes, let those receptors "reset."
The catch is that sermorelin's pharmacology doesn't behave like, say, a continuous-drip drug. Its half-life is roughly 12 minutes. It triggers a discrete GH pulse and then it's gone. The pituitary spends the vast majority of every 24-hour period unstimulated by exogenous peptide, even on a continuous nightly protocol. This is a big part of why published clinical trials have generally used nightly dosing without running into obvious receptor downregulation problems.
Still, the cycling tradition is deeply embedded in compounded peptide practice. It's not baseless, just under-studied. And the protocols below all have reasonable arguments behind them.
The Weekday Protocol: 5 On, 2 Off
This is the most common cycling pattern you'll encounter.
Patients inject nightly Monday through Friday, then skip the weekend. Some reverse it or split the off days (Wednesday and Sunday, for example), but the total is the same: five doses per seven-day period.
The case for it: Regular receptor rest windows. About 28 percent less peptide consumed per month, which adds up. Easy to remember (weekdays on, weekends off).
Where it falls apart a little: The clinical evidence that this pattern actually preserves response better than continuous dosing is thin. And some patients notice their sleep quality dips on the off nights, which can be annoying enough to erode compliance. Two days of receptor rest every week has limited physiological rationale beyond the desensitization theory itself.
Typical fit: Patients on longer courses (six months or more) who want to manage cost, or whose prescribers lean toward the cycling philosophy by default.
Just Injecting Every Night
The simplest version, and also widely used.
Get provider-reviewed GLP-1 therapy
Side effects are manageable with the right support. A licensed provider can adjust your dose when you need it.
Start Free Assessment →The case for it: This is how most published sermorelin research was actually conducted. You get consistent IGF-1 levels without the weekly sleep dip. A daily habit is, for many people, easier to maintain than a weekday-only habit. (There's a reason daily medications have better adherence than every-other-day ones.)
The downside: Slightly more expensive per month. And if you believe in receptor desensitization, you're not giving the pituitary any scheduled rest. That said, the published data doesn't show a meaningful desensitization signal at physiologic doses over months of continuous use.
Typical fit: Patients who value consistent nightly sleep effects, patients who find a simpler routine easier to stick with, or patients whose prescribers prefer sticking close to the published research.
The Long Cycle: 6 Months On, 1 Month Off
This is a macro-level cycling strategy, layered on top of whichever weekly pattern the patient uses.
Run sermorelin nightly (or 5-on-2-off) for six months. Then take a full month completely off before deciding whether to restart.
The case for it: The break month gives the hypothalamic-pituitary axis a genuine reset window. It also allows a clean IGF-1 draw off-therapy, so the prescriber can see where the patient's baseline has actually shifted. And it forces a periodic gut-check: is this peptide still providing enough benefit to justify continuing?
The downside: Patients almost universally report some degree of sleep and energy regression during the break month. Restarting from scratch every seven months can feel disruptive, like losing momentum.
Typical fit: Patients on indefinite long-term protocols, prescribers who want periodic clean labs, or patients who want a structured cadence for re-evaluating whether sermorelin is still worth it.
Dose and Cycling Are Connected
Here's the thing most cycling discussions miss: the lower the dose, the less cycling probably matters.
A patient on 200 mcg nightly is producing modest GH pulses. The pituitary handles that without strain. The case for periodic rest gets stronger at higher doses (400 to 500 mcg), where receptor occupation per dose is more substantial.
Some prescribers address this neatly by prescribing continuous dosing at conservative doses and switching to 5-on-2-off only when they push the dose higher. Others apply the same cycling protocol regardless of dose. Both approaches are defensible. Neither has a randomized trial behind it. (Welcome to compounded peptide medicine.)
What Cycling Doesn't Fix
A few misconceptions that come up repeatedly:
Cycling won't eliminate side effects. If continuous dosing caused glucose elevation or edema, cycling will likely reduce the severity, but probably not eliminate it entirely.
Cycling doesn't extend benefits into the off period. Most sermorelin effects gradually fade during a break. You don't "bank" GH pulses.
Cycling doesn't rescue a non-responder. Three months of continuous dosing with no meaningful IGF-1 change or symptom improvement is not going to be solved by switching to a 5-on-2-off pattern. The problem is upstream of scheduling.
And cycling doesn't replace monitoring. IGF-1 trends, metabolic markers, and clinical reassessment matter regardless of which pattern you're on.
A Practical Decision Framework
Most prescribers, in my observation, default to something like this:
- New patient, conservative starting dose: continuous nightly dosing. Keep it simple, build the habit, establish a baseline response.
- Patient at a higher maintenance dose with documented good response: 5-on-2-off is a reasonable option, especially if cost is a factor.
- Patient on indefinite long-term therapy: build in a structured break, usually one month off after every six months on.
- Patient with response decay over time (rising dose needed for the same IGF-1 bump): try a structured one-month break, then reassess.
When restarting after a long break, some prescribers recommend a half-dose ramp for the first week. This is cautious rather than evidence-based; side effect profiles on restart usually look similar to the original course whether you ramp or not. Lab work at the end of a break, before restarting, is genuinely useful. It shows where IGF-1 settles without therapy and gives a cleaner measuring stick for the next cycle.
My honest take: for most adult patients at standard physiologic doses, the difference between continuous and 5-on-2-off is probably small enough that convenience and cost should drive the decision, not anxiety about receptor desensitization. The 6-month break, on the other hand, has real clinical value for anyone planning to stay on sermorelin indefinitely, if only because it forces a periodic check-in with actual off-therapy data.
FAQ
Do I need to cycle sermorelin? No single cycling protocol is definitively required. Continuous nightly, 5-on-2-off, and 6-months-on with a break are all used in clinical practice. Your prescriber should set the pattern based on your dose, goals, and response.
Will cycling preserve my response longer? The theory is plausible but direct human evidence is limited. Some prescribers are strongly convinced; others aren't. In practice, outcomes between continuous and 5-on-2-off appear similar at physiologic doses.
Do I lose benefits on the off days? Some patients notice mild sleep regression on the off nights of a 5-on-2-off protocol. Body composition and IGF-1 effects are not noticeably degraded by a couple of missed nights per week.
What's the longest I can stay on sermorelin? No firm published upper limit exists at physiologic doses. Most prescribers prefer at least one structured break per year to pull clean labs and reassess clinical benefit.
Can I just decide my own cycling pattern? The cycling pattern should be part of the prescribed protocol, including monitoring labs. Self-adjusting the schedule makes it harder to interpret your response, and harder for your prescriber to help you troubleshoot if something changes.
---
Sermorelin is not FDA-approved for the treatment of any condition in adults. Compounded sermorelin is prepared by licensed pharmacies for individual patients based on a prescriber's clinical judgment. This article is educational only and does not constitute medical advice. Talk to a qualified clinician before starting any peptide therapy.
Related reading: Sermorelin Dosage Protocols | Sermorelin Results Timeline | Sermorelin Benefits and Research | Sermorelin Side Effects Explained | Order Compounded Sermorelin